B. Coller

发表

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.

R. Warrell, M. Hultin, B. Coller, 1979, The American journal of medicine.

Three novel β‐propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro‐αIIb, but variably impaired progression of pro‐αIIbβ3 from endoplasmic reticulum to Golgi

M. Chandy, A. Srivastava, B. Coller, 2005 .

Role of P‐selectin, β2‐integrins, and Src tyrosine kinases in mouse neutrophil–platelet adhesion

S. Smyth, V. Evangelista, S. Manarini, 2003, Journal of thrombosis and haemostasis : JTH.

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

H. Hemker, S. Béguin, B. Coller, 1996, The Journal of clinical investigation.

Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor.

H. Hemker, S. Béguin, R. Kumar, 1999, Blood.

B. Coller, M. Ginsberg, R. McEver, 1985, Blood.

Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities.

J. Conboy, V. Afzal, B. Coller, 1999, The Journal of clinical investigation.

Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor.

B. Coller, B. Coller, L. Scudder, 1985, Blood.

A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia.

M. Poncz, J. Gill, B. Coller, 1991, The Journal of clinical investigation.

Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein (cid:1) IIb (cid:2) 3 (GPIIb/IIIa) and (cid:1) v (cid:2) 3 Receptors Are Not Protected From Atherosclerosis

D. Harats, O. Shpilberg, K. Schiller, 2002 .

Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.

D. S. Neblock, H. Weisman, R. Jordan, 1996, Blood.

7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli.

R. Jordan, C. Esmon, F. Taylor, 1997, Blood.

Glanzmann thrombasthenia secondary to a Gly273-->Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb.

P. Fortina, B. Coller, M. Poncz, 1994, The Journal of clinical investigation.

Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis

U. Seligsohn, B. Coller, P. Little, 1987 .

The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.

B. Coller, 1978, The Journal of clinical investigation.

Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents.

B. Coller, 1981, Blood.

A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.

C. Grimaldi, B. Coller, D. French, 1996, Blood.

Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor.

R. Nagel, X. Liu, D. Kaul, 2000, Blood.

Electrophoretic mobility of platelets from normal and bleeder swine.

D. Fass, B. Coller, 1979, Thrombosis research.

Asialofibrinogen supports platelet aggregation and adhesion to glass.

B. Coller, 1979, Blood.

Platelet interaction with subendothelial extracellular matrix: platelet-fibrinogen interactions are essential for platelet aggregation but not for the matrix-induced release reaction.

Z. Fuks, A. Eldor, I. Vlodavsky, 1985, Blood.

ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders

B. Coller, A. Tosetto, P. James, 2010, Journal of thrombosis and haemostasis : JTH.

Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis.

L. Hoyer, M. Hultin, B. Coller, 1981, Blood.

Platelet membrane studies in the May-Hegglin anomaly.

B. Coller, M. Zarrabi, M. H. Zarrabi, 1981, Blood.

Effects of tertiary amine local anesthetics on von Willebrand factor- dependent platelet function: alteration of membrane reactivity and degradation of GPIb by a calcium-dependent protease(s)

B. Coller, 1982 .

Partial characterization of a binding site for von Willebrand factor on glycocalicin.

J. Loscalzo, A. Michelson, R. Handin, 1986, Blood.

Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell–endothelium interactions induced by platelet-activating factor

R. Nagel, Xiaodong Liu, D. Kaul, 2000 .

A murine monoclonal antibody that blocks fibrinogen binding to normal platelets also inhibits fibrinogen interactions with chymotrypsin-treated platelets.

B. Coller, E. Peerschke, 1984, Blood.

Aplastic anemia in pregnancy: recovery after normal spontaneous delivery.

I. Goldstein, B. Coller, 1975, Annals of internal medicine.

Hematologically important mutations: Glanzmann thrombasthenia.

D. French, B. Coller, Deborah L. French, 1997, Blood cells, molecules & diseases.

Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

R. Hynes, B. Coller, D. Crowley, 1999, The Journal of clinical investigation.

Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.

H. Dietz, R. Montgomery, P. Bray, 1996, The Journal of clinical investigation.

Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.

S. Karpatkin, B. Coller, C. Ambrogio, 1988, The Journal of clinical investigation.

Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients

B. Coller, M. Chandy, S. Nair, 2006, Journal of thrombosis and haemostasis : JTH.

Intravenous gammaglobulin therapy in the management of a patient with idiopathic thrombocytopenic purpura and a warm autoimmune erythrocyte panagglutinin during pregnancy.

S. Saletan, M. Hultin, B. Coller, 1986, Obstetrics and gynecology.

Protein S deficiency associated with central retinal artery occlusion.

P. Sibony, B. Coller, B. Golub, 1990, Archives of ophthalmology.

Severe von Willebrand's disease during labor and delivery.

J. Ayromlooi, B. Coller, R. Lipton, 1982, JAMA.

Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction – A post hoc analysis of the cel-02 phase IIa study

C. Gibson, O. Bentur, K. Zheng, 2023, American heart journal.

Preclinical and Human Phase 1 Studies of Aerosolized Hydroxychloroquine: Implications for Antiviral COVID-19 Therapy

H. Boushey, A. Krieger, O. Bentur, 2023, medRxiv.

A 13‐bp deletion in αIIb gene is a founder mutation that predominates in Palestinian‐Arab patients with Glanzmann thrombasthenia

M. Landau, B. Coller, G. Kenet, 2005, Journal of thrombosis and haemostasis : JTH.

A monoclonal antibody to the fibrinogen γ‐chain alters fibrin clot structure and its properties by producing short, thin fibers arranged in bundles

J. Weisel, B. Coller, B. Coller, 2003, Journal of thrombosis and haemostasis : JTH.

Polybrene-induced platelet agglutination and reduction in electrophoretic mobility: enhancement by von Willebrand factor and inhibition by vancomycin

B. Coller, 1980 .

Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel.

B. Coller, D. Cheresh, E. Asch, 1991, Blood.

Management of factor XI deficiency in gynecologic and obstetric patients.

M. Steinberg, S. Saletan, B. Coller, 1986, Obstetrics and gynecology.